Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells.
about
Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1T cell receptor gene therapy for cancerAntigen processing in vivo and the elicitation of primary CTL responsesIdentification of human cancers deficient in antigen processingAdoptive T cell therapy for cancer in the clinicSynthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTLDendritic cells: In the forefront of immunopathogenesis and vaccine development - A reviewAdoptive T cell therapy: Addressing challenges in cancer immunotherapyEnhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity.Distribution, persistence, and efficacy of adoptively transferred central and effector memory-derived autologous simian immunodeficiency virus-specific CD8+ T cell clones in rhesus macaques during acute infection.Trafficking, persistence, and activation state of adoptively transferred allogeneic and autologous Simian Immunodeficiency Virus-specific CD8(+) T cell clones during acute and chronic infection of rhesus macaquesTumor mouse model confirms MAGE-A3 cancer immunotherapeutic as an efficient inducer of long-lasting anti-tumoral responses.Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.Polyomavirus-infected dendritic cells induce antiviral CD8(+) T lymphocytes.Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer.Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cellsCell-mediated immune response to human papillomavirus infection.Principles of adoptive T cell cancer therapy.Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase.Global gene expression profiling in interleukin-12-induced activation of CD8(+) cytotoxic T lymphocytes against mouse mammary CarcinomaHigh-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma.Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cellsA CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors.Systemic distribution and tumor localization of adoptively transferred lymphocytes in mice: comparison with physiologically based pharmacokinetic model.Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies.Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friendsThe immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein.Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopesProlonged overall survival in gastric cancer patients after adoptive immunotherapyCytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cellsNaive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors.Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4+ Th1 Cells.Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigenCD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses.A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.
P2860
Q24633445-20E75D77-07EB-4433-A244-11EAE02C278FQ24634774-C668DA6F-55C7-4E87-9958-FBBF4ADDF8B2Q24675502-53C141D0-BFAB-48D6-B7A9-46E960366533Q24678495-C65B2108-BB98-4351-B912-F995200F80DFQ24680405-A2B1818B-2901-4904-A906-7D631AF821CCQ24684276-7051D3D7-333F-474B-8669-52D0D060B844Q24792153-C9502431-690B-44DC-B738-394A75B46681Q24805804-D20C8609-9B29-4A8D-86C3-2247616C96FAQ28476101-32C4E0FE-DE07-4D46-BF8E-894DE7FEF3C2Q30769959-824196C3-2746-466D-946E-4D3247BD7B2EQ33554940-E30E5DEB-1CC6-42EF-AD40-113AA89F1FA9Q33554963-38F3A693-5886-4F67-964F-1A5ACF3FC6B9Q33617905-6FF7B937-573D-48E4-95AB-CDB1E748CD7EQ33653487-8B5F7153-6658-4DAD-9BF7-F86F7707908EQ33803386-184F740B-2463-45B5-A892-8C994E42EA33Q33808144-B6FD9EF0-6A98-4343-850D-803D3405C0F1Q33848587-AC7D6836-87A1-4FCE-92ED-BC9260D79C8AQ33998922-9E398B74-560B-4F68-8E03-C7D7A0E8B896Q34003932-58A717C8-8849-40AE-963B-788B2EDDED6FQ34027192-38A03978-872B-4A88-AB74-C94F5E495CC6Q34243372-0B5FEC07-D24D-4E30-8F51-43D79CFDA60FQ34245822-5DF9C664-6C9B-49A8-A1E5-617DF902909FQ34256122-E69574ED-3726-4A06-B38F-EC911EE3515EQ34415738-17C19A43-6B4E-44A4-B8CF-A591C80BFF0BQ34568823-DEE3BB93-21DF-47DD-A173-FAC0713AD1D6Q34775046-80581240-A9F6-4134-85A1-F138826F875AQ34898280-C55B9EF0-532D-4AA4-9A1E-CEF1D1F4B1EFQ35001627-197E4EA2-7B18-42E2-9FAB-63E03A7412C8Q35049933-8A4F8BEE-9EE9-4ABE-9AA5-0174790F82A9Q35093159-FA53CCF7-BCFB-497C-8696-C512C6DA2A03Q35152386-D5A0E42A-F1E8-4C2B-8738-E0951B748913Q35227334-029F42EB-0D27-48B9-9B07-0FCFAFFA4F04Q35525622-85B17C3A-128A-4924-8066-223A3D694763Q35628806-31C83CE6-AF9C-409D-A5D0-2F8B8CCE1E2DQ35731386-62FF45DE-6AC1-4591-9E5D-441B8C3EE8DEQ35872183-AD62EBAD-BB20-43F9-ADDC-D69DFD1344DCQ35945206-3744A51D-D792-4D72-B4F9-C98E42BEC080Q35978636-B13FEAA5-3B4A-4071-9C55-8B4C88D8C83FQ35987503-3D2D64FD-6657-4D63-B92F-C06055293895Q35990356-99377DA7-C8C4-481E-A0E8-94463C368DC4
P2860
Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adoptive T cell therapy of tum ...... nd elimination of tumor cells.
@en
Adoptive T cell therapy of tum ...... nd elimination of tumor cells.
@nl
type
label
Adoptive T cell therapy of tum ...... nd elimination of tumor cells.
@en
Adoptive T cell therapy of tum ...... nd elimination of tumor cells.
@nl
prefLabel
Adoptive T cell therapy of tum ...... nd elimination of tumor cells.
@en
Adoptive T cell therapy of tum ...... nd elimination of tumor cells.
@nl
P1476
Adoptive T cell therapy of tum ...... nd elimination of tumor cells.
@en
P2093
Greenberg PD
P304
P577
1991-01-01T00:00:00Z